All Articles Tagged With: "Vytorin"
Articles
Vytorin Cancer Link Not Seen by FDA
Federal regulators indicate that it is unlikely that the cholesterol drug Vytorin causes cancer, despite a clinical study in 2008 which raised potential Vytorin cancer concerns.
Zetia, Vytorin Problems Continue With Latest Study
In the latest blow to popular cholesterol drugs Vytorin and Zetia, new research indicates that the medications may be less effective than older drugs in reducing the buildup of cholesterol in arteries, and were actually associated with more heart attacks and other heart-related incidents.
Zetia and Vytorin Side Effects Not Linked to Cancer According to Study
Despite reports that emerged last year linking side effects of Vytorin and Zetia to an increased incidence of cancer, a new study suggests that the cholesterol drugs are not associated with an increased risk of cancer.
FDA Indicates Vytorin and Other Cholesterol Drugs Should Not Be Stopped
Despite concerns which emerged last year about whether Vytorin provides any benefits over cheaper, generic alternatives, the FDA indicated last week that their review of available data does not suggest that patients should stop taking the cholesterol lowering drug.
Vytorin Class Action Lawsuits Mount as Justice Deptartment Investigates
Merck & Co. and Schering-Plough Corp. currently face around 140 Vytorin class action lawsuits involving their once-popular cholesterol drug, which has been shown to provide no medical benefits over cheaper generic alternatives. In addition, this week the drug makers disclosed that the U.S. Department of Justice is now investigating their marketing of the medication. [...]
New Haven Connecticut Plans to File Vytorin Lawsuit
The city of New Haven, Connecticut, has indicated that they plan to file a Vytorin lawsuit against Merck and Schering-Plough to recover over $400,000 in prescription costs paid for employees who received the cholesterol drug that has been found to provide no medical benefit.
Researcher Claims “No Credible Evidence” of Vytorin Cancer Side Effects
In response to concerns about a potential link between Vytorin and cancer, the FDA has initiated a safety review and members of Congress have requested additional information about the potential side effect. However, a prominent researcher released a letter this week in response to the congressional probe indicating that there is “no credible evidence” [...]
NEJM: Too Soon To Dismiss Vytorin Cancer Connection
According to an editorial published in the New England Journal of Medicine, it is too early to rule out concerns about a possible Vytorin cancer connection that was identified in recent study data. The makers of Vytorin had previously sent a letter to healthcare providers dismissing the findings as likely attributed to chance.
FDA Investigating Link between Vytorin and Cancer
The FDA released an early communication yesterday, about an investigation into the possible association between cancer and Vytorin, Zetia and Zocor.
Rhabdomyolysis Warning Issued by FDA
The FDA issued an alert on Friday to remind doctors and the public about the risk of rhabdomyolysis, a rare and potentially fatal muscle condition, which could arise from the combined use of cholesterol drugs containing simvastatin, such as Zocor, Vytorin and Simcor, and heart drugs containing amiodarone, such as Cordarone and Pacerone.
